AzTrials
AzTrials

High Intensity Interval TrainingNCT06754475

Effects of Upper Extremity Low Volume HIIT in Heart Failure

A study testing Low-volume, high-intensity interval training and Standart medical treatment in people with High Intensity Interval Training and Heart Failure, run by Tarsus University at 2 sites in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study was planned to investigate the effects of upper extremity low-volume high-intensity interval training (LV-HIIT) on physical and cognitive function in patients with heart failure with preserved ejection fraction(HFpEF).The research was planned as a randomized controlled trial. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Low-volume, high-intensity interval training and Standart medical treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
2 sitesTurkey (Türkiye)
Study dates
1 Nov 2024to 1 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Clinical condition stable for ≥4 weeks.
  • New York Heart Association functional classification I-II to III
  • Over 18 years old

Who cannot join

  • History of CABG surgery
  • Unstable angina pectoris
  • Severe arrhythmia
  • Acute pericarditis, endocarditis, myocarditis
  • Severe left ventricular failure (EF <40%)
  • Acute pulmonary embolism
Show all 15Show fewer
  • History of syncope
  • Dissecting aneurysm
  • Thrombophlebitis
  • Orthopedic disorders that may interfere with exercise
  • Uncontrolled hypertension, severe pulmonary arterial hypertension
  • Moderate-severe valve disease
  • Decompensated Congestive Heart Failure
  • Electrolyte abnormalities
  • Hypertrophic Cardiomyopathy

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Nurel ERTÜRK contact

+905056637544

nrlbllr@gmail.com

Turkey (Türkiye)2 sites, 2 recruiting
  • Tarsus University, TARSUS, Mersin

    Mersin, Mersin

    Nurel Ertürk, 05056637544, nrlbllr@gmail.com

    Recruiting
  • Nurel Ertürk, TARSUS, Mersin

    Yenişehir, Mersin

    Nurel Ertürk, 05056637544

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Upper Extremity Low-Volume High-Intensity Interval Training on Physical and Cognitive Functions in Heart Failure Patients

This study was planned to investigate the effects of upper extremity low-volume high-intensity interval training (LV-HIIT) on physical and cognitive function in patients with heart failure with preserved ejection fraction(HFpEF).The research was planned as a randomized controlled trial. Patients with clinically stable HFpEF at cardiology clinic will be included in the study. These cases will be randomly divided into two groups: intervention group and control grup. After 8 weeks intervention physical functions before and after treatment; functional exercise capacity, arm exercise capacities , peripheral muscle strength , fatigue cognitive functions; anxiety and depression and fear of movement will be evaluated.

Read the detailed description

Patients in the DV-HIIT group will receive training consisting of 4 minutes of warm-up and cool-down at 50% Wmax on an arm ergometer, 1 minute of training at 85-95% Wmax work intensity, followed by 6 interval training periods including 1 minute of active recovery periods at 50-70% Wmax, 2 days/week, totaling 8 weeks of training. The control group will be followed with standard medical treatment.

Being tested
Low-volume, high-intensity interval training, Standart medical treatment
Keywords
high intensity interval training, upper extremity, exercises capacity
Medical subject headings
Heart Failure, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low-volume, high-intensity interval trainingOther

    Low-volume, high-intensity interval training with an arm ergometer will be given two days a week for a total of eight weeks.

  • Standart medical treatmentDrug

    Standart medical teatment

Study groups in NCT06754475
Study groupRoleWhat they receive
PatientsExperimentalİntervention Group: LV-HIIT
Receives: Other: Low-volume, high-intensity interval training
Control groupOtherControl group
Receives: Drug: Standart medical treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. maximal arm exercises capacity

    maximal arm exercises capacity will measurement with arm ergometer test.

    Measured: At baseline and after 8 week

  2. Functional capacity

    Functional capacity will be assessed with the six-minute walk test (6MWT).

    Measured: At baseline and after 8 week

  3. Upper extremity muscle strength

    Upper extremity muscle strength will be evaluated with a digital dynamometer and hand grip strength will be evaluated with a jamar.

    Measured: At baseline and after 8 week

  4. reaction time

    The auditory and visual reaction times of the individuals will be determined. The instrument used during the test can give three stimuli and consists of two parts, In measuring the reaction times, care will be taken to ensure that the measurement area is a noiseless and light-receiving environment. Individuals will be told the technique of the test and will be asked to make 1 attempt against sound and light stimulation. After the trial, 3 measurements will be taken and the results will be recorded in milliseconds

    Measured: At baseline and after 8 week

  5. cognitive function

    Mini mental Questionaire will use. Min 24 point is the cut of for this test

    Measured: At baseline and after 8 week

  6. Postural sway

    The postural oscillations of the patients will be evaluated with the body oscillation device, which measures the oscillation in two axes. In this test, the participant will be asked to stand in the upright position with a distance of 10 cm between the two feet and to maintain your upright position for 30 seconds. The participant will be measured twice with the eyes open and closed. With these measurements, the mediolateral and anteroposterior oscillation distances of the patients will be measured and recorded on the computer

    Measured: At baseline and after 8 week

  7. heart rate variablity

    Measured: At baseline and after 8 week

Secondary outcomes (3)
  1. hand steadness

    The auditory and visual reaction times of the individuals will be determined. The instrument used during the test can give three stimuli and consists of two parts, In measuring the reaction times, care will be taken to ensure that the measurement area is a noiseless and light-receiving environment. Individuals will be told the technique of the test and will be asked to make 1 attempt against sound and light stimulation. After the trial, 3 measurements will be taken and the results will be recorded in milliseconds.

    Measured: At baseline and after 8 week

  2. Anxiety and depresion

    Hospital anxiety and depression Scale is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3). It is designed to measure anxiety and depression (7 items for each subscale). The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21). It is worth noting that items referring to depression symptoms that describe somatic aspects of depression (e.g. insomnia and weight loss) are not included in the scale.

    Measured: At baseline and after 8 week

  3. activities of daily living

    Nottingham Health Profile (NHP) will used. The questionnaire is divided into two parts. The first parts comprises 38 questions in six categories: sleep, physical mobility, energy, pain, emotional reactions, and social isolation.The second part of the NHP is made up of seven statements about areas of life that are commonly affected by health: paid employment, jobs around the house, social life, personal relationships, sex life, hobbies and interests, and holidays. Scores on the NHP can range from 0 i.e. no distress to 100 i.e severe distress.

    Measured: At baseline and after 8 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Dec 2024
  2. Study start1 Nov 2024
  3. Primary completion1 Nov 2026 (estimated)
  4. Study completion1 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomised controlled trial
Masking
Single blind
Who is masked
Participant
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06754475
Sponsor's protocol ID
2024/17
Status last verified
Nov 2024
First submitted
23 Dec 2024
Last updated
3 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: All IPD collected throughout the trial, only IPD used in the results publication

Questions about this trial

What is this clinical trial studying?

A study testing Low-volume, high-intensity interval training and Standart medical treatment in people with High Intensity Interval Training and Heart Failure, run by Tarsus University at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nurel ERTÜRK (+905056637544, nrlbllr@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

maximal arm exercises capacity (time frame: At baseline and after 8 week). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in